From Howard Lotsof to High-Tech Healing: The Evolution of Ibogaine and the Rise of Specialized Medicine in Mexico

In the history of medicine, the most profound discoveries are often accidents. Penicillin was a moldy petri dish; the X-ray was a glowing screen in a dark lab. And the cure for the modern opioid crisis? It was discovered in 1962 by a 19-year-old heroin addict named Howard Lotsof, who was simply looking for a…

Read More

Sustainable Joy: The Science and Strategy of Ongoing Noribogaine Maintenance for Depression

In the treatment of depression, the medical world is obsessed with the daily pill. The prevailing assumption is that brain chemistry requires constant, artificial tampering—a daily dose of SSRIs or SNRIs to keep serotonin afloat. But biology often works in cycles, not straight lines. At Ibogaine by David Dardashti, we are challenging the daily-pill paradigm….

Read More

Beyond the SSRI: How Algorithmic Precision and Abstract Mathematics Are Revolutionizing Ibogaine Treatment for Resistant Depression

By David Dardashti Topic: Neuro-Pharmacology   Mental Health Innovation  Read Time: 10 Minutes The current landscape of depression treatment is characterized by a tragic lack of precision. For decades, psychiatry has relied on a “throw everything at the wall and see what sticks” approach—cycling patients through SSRIs, SNRIs, and talk therapies with widely variable results. When…

Read More

Standing Up for Seniors: The Critical Role of a Nursing Home Abuse Lawyer Today

The decision to place a loved one in a nursing home carries both hope and vulnerability. Families hope for professional care, a safe environment, and compassionate support. Yet for many seniors, the reality becomes a quiet battlefield where neglect, mistreatment, and exploitation may remain hidden behind closed doors. As elder abuse cases rise nationwide, the…

Read More

Nearly 6 in 10 Fatal Crashes Happen After Dark in America’s Largest States

A new traffic safety analysis from Omega Law Group of the five most populous U.S. states has found that nighttime driving is significantly more deadly than daytime travel, with 58% of all traffic fatalities occurring after dark between 2019 and 2023. The whitepaper, which examines crash data from California, Texas, Florida, New York, and Pennsylvania,…

Read More

Billions on the Line: October’s Surge, Texas’s Outlier Status, and Georgia’s Mirror of National Risk

The economic impact of U.S. traffic crashes exceeds $340 billion annually, according to federal estimates. A new analysis from John Foy & Associates explains how predictable, seasonal risk patterns, especially October’s recent rise to the deadliest month, offer states a practical roadmap to save lives and reduce costs fast. Using NHTSA datasets, the analysis documents…

Read More
The Psychedelic Mirror: How Ibogaine Unravels the Self and Heals Trauma

The Psychedelic Mirror: How Ibogaine Unravels the Self and Heals Trauma

The resurgence of ibogaine in medical and therapeutic discourse isn’t just about addiction interruption; it’s about a profound, introspective journey that can fundamentally rewire an individual’s psychological landscape. Beyond its neurochemical impact, ibogaine acts as a potent tool for accessing the deeper layers of the psyche, offering a unique opportunity to engage with Jungian archetypes…

Read More
The Algorithmic Architect: How Ibogaine Software, Championed by David Dardashti, is Revolutionizing Personalized Dosing

The Algorithmic Architect: How Ibogaine Software, Championed by David Dardashti, is Revolutionizing Personalized Dosing

The powerful plant alkaloid ibogaine is known for its ability to dramatically interrupt patterns of addiction and offer profound psychological insights. However, the complexity of ibogaine—particularly its potential to induce cardiotoxicity (QTc prolongation)—demands treatment protocols that are exceptionally rigorous and personalized. Pioneers in the field, such as David Dardashti of Ibogaine by David Dardashti, have…

Read More

Subscribe to Our Newsletter